Elsevier Brings Together Leading Experts From Around the World for DIAMOND 2011 Conference

Conference Will Focus on the Fields of Diamond, Diamond-like Compounds, Carbon Nanotubes, Graphene, and Nitrides

NEW YORK, January 10, 2011 - Elsevier announced today that DIAMOND 2011, 22nd European Conference on
Diamond, Diamond-Like Materials, Carbon Nanotubes and Nitrides, will occur on
4-8 September 2011 in Garmisch-Partenkirchen, Bavaria, Germany. The Elsevier
organized conference discusses the significant improvements in material
growth processes, material purity and doping of these materials over the past
few years. The improvements have lead to the discovery of new phenomena in
these materials as well as to novel device applications with increasingly
impressive performance levels.

The conference is now accepting abstracts for oral and paper
presentations in the topics of diamond, diamond-like carbon, carbon
nanotubes, graphene, and III-nitrides: growth properties and applications.
Abstract submissions should be made through the online abstract submission
system at www.diamond-conference.elsevier.com. The deadline for
abstract submission is March 3, 2011.

"Elsevier is very excited to be organizing DIAMOND 2011 in collaboration
with the scientific community," said Allyn Molina, Elsevier Publisher.
"Building on the success of last year's conference, the program will continue
to bring a broad spectrum of speakers and topics that present the current
state of diamond science."

"In 2011 we expect significant progress with respect to single
crystalline diamond wafer production as well as quantum effects in diamond
applied for quantum computing, cryptography and magnetic field sensing,"
commented Christoph Nebel, conference Chair and Professor at Fraunhofer
Institut fur Angewandt Festkorperphysik (IAF), Germany. "These topics are at
the leading edge of semiconductor research, utilizing the unique properties
of diamond for novel semiconductor applications of the near future and will
be addressed at DIAMOND 2011."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
(www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/home.url), Reaxys (
notice.reaxys.com/maintenance.html), MD Consult (
www.mdconsult.com/php/222075573-2/homepage) and Nursing Consult
(www.nursingconsult.com/php/222075595-2/home.html), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com/) and MEDai's Pinpoint Review (www.medai.com/),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC (
www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Jason Awerdick
    +1-212-633-3103
    j.awerdick@elsevier.com

Media Contact: Jason Awerdick, +1-212-633-3103, j.awerdick at elsevier.com